Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fanny Boursin"'
Autor:
Nicolas Aubrey, Valérie Gouilleux-Gruart, Christine Dhommée, Julie Mariot, Fanny Boursin, Nicolas Albrecht, Cécile Bergua, Cécile Croix, Mäelle Gilotin, Eloi Haudebourg, Catherine Horiot, Laetitia Matthias, Caroline Mouline, Laurie Lajoie, Audrey Munos, Gilles Ferry, Marie-Claude Viaud-Massuard, Gilles Thibault, Florence Velge-Roussel
Publikováno v:
Antibodies, Vol 11, Iss 3, p 54 (2022)
Bispecific antibodies (BsAbs) represent an important advance in innovative therapeutic strategies. Among the countless formats of BsAbs, fusion with molecules such as anticalins linked to a monoclonal antibody (mAb), represents an easy and low-cost w
Externí odkaz:
https://doaj.org/article/c53d720fbba84a0fb3de25e6b0f595e5
Autor:
Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot, Fanny Boursin, Cyril Colas, Stéphanie Letast, Caroline Denevault-Sabourin, Emilie Allard-Vannier, Nicolas Joubert, Nicolas Aubrey
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1524 (2022)
Antibody–drug conjugates (ADCs) derived from a full immunoglobulin-G (IgG) are associated with suboptimal solid-tumor penetration and Fc-mediated toxicities. Antibody fragment–drug conjugates (FDCs) could be an alternative. Nevertheless, innovati
Externí odkaz:
https://doaj.org/article/15b7c6d9bacf44478b679c4b9bf364c0
Autor:
Thomas Cnudde, Zineb Lakhrif, Justine Bourgoin, Fanny Boursin, Catherine Horiot, Corinne Henriquet, Anne di Tommaso, Matthieu Olivier Juste, Isabella Gizzi Jiacomini, Isabelle Dimier-Poisson, Martine Pugnière, Marie-Nöelle Mévélec, Nicolas Aubrey
Publikováno v:
Antibodies, Vol 9, Iss 2, p 9 (2020)
In order to increase the successful development of recombinant antibodies and fragments, it seems fundamental to enhance their expression and/or biophysical properties, such as the thermal, chemical, and pH stabilities. In this study, we employed a m
Externí odkaz:
https://doaj.org/article/733e1c4a224c449c9be3156c5354bb95
Autor:
Sabrina Karim-Silva, Alessandra Becker-Finco, Isabella Gizzi Jiacomini, Fanny Boursin, Arnaud Leroy, Magali Noiray, Juliana de Moura, Nicolas Aubrey, Philippe Billiald, Larissa M. Alvarenga
Publikováno v:
Toxins, Vol 12, Iss 4, p 256 (2020)
Envenoming due to Loxosceles spider bites still remains a neglected disease of particular medical concern in the Americas. To date, there is no consensus for the treatment of envenomed patients, yet horse polyclonal antivenoms are usually infused to
Externí odkaz:
https://doaj.org/article/01fd7b5658304999ae5a2c1ba709d3cb
Autor:
Aubrey, Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot, Fanny Boursin, Cyril Colas, Stéphanie Letast, Caroline Denevault-Sabourin, Emilie Allard-Vannier, Nicolas Joubert, Nicolas
Publikováno v:
Pharmaceutics; Volume 14; Issue 8; Pages: 1524
Antibody–drug conjugates (ADCs) derived from a full immunoglobulin-G (IgG) are associated with suboptimal solid-tumor penetration and Fc-mediated toxicities. Antibody fragment–drug conjugates (FDCs) could be an alternative. Nevertheless, innovati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::66c0f7274d315b7b9af5c4ab1244e1f9
Autor:
Isabella Gizzi Jiacomini, Martina Beltramino, Fanny Boursin, João Carlos Minozzo, Juliana Ferreira de Moura, Philippe Billiald, Larissa Magalhães Alvarenga, Nicolas Aubrey
Publikováno v:
International journal of biological macromolecules. 216
The use of monoclonal antibodies (mAbs) in therapy is gradually advancing and discussions entail its safety, rentability and effectiveness. To this date, around a hundred mAbs have been approved by the FDA for the treatment of various diseases. Aimin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce76b5590be797a555f1d157ea36a6e
https://pubmed.ncbi.nlm.nih.gov/35803408
https://pubmed.ncbi.nlm.nih.gov/35803408
Autor:
Chunlei Su, Déborah Voisin, Yohan Villain, Radu Blaga, Isabelle Vallée, Sébastien Perrot, Solen Morisse, Vitomir Djokic, Anne-Claire Lagrée, Edouard Seche, Fanny Boursin, Delphine Le Roux, Vanessa Doré, Aurélie Grasset-Chevillot, Clément Chauvin
Publikováno v:
Vaccine
Vaccine, Elsevier, 2020, 38 (6), pp.1457-1466. ⟨10.1016/j.vaccine.2019.11.076⟩
Vaccine, Elsevier, 2020, 38 (6), pp.1457-1466. ⟨10.1016/j.vaccine.2019.11.076⟩
International audience; Toxoplasmosis is a zoonotic disease caused by the parasite Toxoplasma gondii. Up to a third of the global human population is estimated to carry a T. gondii infection, which can result in severe complications in immunocompromi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a9787fd6bd65bbb02f529433745a52
https://pubmed.ncbi.nlm.nih.gov/31864855
https://pubmed.ncbi.nlm.nih.gov/31864855